ACA 100 mg (Calquence 100 mg)
Generic Name: acalabrutinib
Pill with imprint ACA 100 mg is Blue & Yellow, Capsule-shape and has been identified as Calquence 100 mg. It is supplied by AstraZeneca.
Calquence is used in the treatment of chronic lymphocytic leukemia; mantle cell lymphoma and belongs to the drug class BTK inhibitors. Calquence 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ACA 100 mg
Calquence
- Generic Name
- acalabrutinib
- Imprint
- ACA 100 mg
- Strength
- 100 mg
- Color
- Blue & Yellow
- Size
- 1.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Btk inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-0512
- Inactive Ingredients
-
microcrystalline cellulose,
corn starch,
magnesium stearate,
sodium starch glycolate type A potato,
gelatin,
titanium dioxide,
ferric oxide yellow,
FD&C Blue No. 2,
silicon dioxide
Note: Inactive ingredients may vary.
Related Images for "ACA 100 mg"
More about Calquence (acalabrutinib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: BTK inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.